Page 20 - ebook
P. 20
고형암 항암치료 환자의 부작용 관리 Nausea and Vomiting
Classification Agent
Oral Low-moderate Pemigatinib
emetic risk Pexidartinib
Pomalidomide
Pnatinib
Praisetinib
Regorafenib
Ribociclib
Ripretinib
Ruxolitinib
Selpercatinib
Sonidegib
Sorafenib
Sunitinib
Talazoparib tosylate
Tazemetostat
Temozolomide ≤75 mg/m day
2
Thalidomide
Thiguanine
Topotecan
Trametinib
Tretinoin
Trifluridine/tipiracil
Tucatinib
Vandetanib
Vemurafenib
Venetoclax
Vismodegib
Vorinostat
Zanubrutinib
20
